Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells.
about
Podocalyxin enhances breast tumor growth and metastasis and is a target for monoclonal antibody therapyCo-Expression of Ezrin-CLIC5-Podocalyxin Is Associated with Migration and Invasiveness in Hepatocellular CarcinomaThe cell surface mucin podocalyxin regulates collective breast tumor budding.Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivoExtracellular microvesicles and invadopodia mediate non-overlapping modes of tumor cell invasion.Bmi1 essentially mediates podocalyxin-enhanced Cisplatin chemoresistance in oral tongue squamous cell carcinomaMicroRNA-375 Suppresses Extracellular Matrix Degradation and Invadopodial Activity in Head and Neck Squamous Cell CarcinomaPrognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancerCUB domain-containing protein 1 and the epidermal growth factor receptor cooperate to induce cell detachment.Extracellular translationally controlled tumor protein promotes colorectal cancer invasion and metastasis through Cdc42/JNK/ MMP9 signaling.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1.The epithelial-mesenchymal transition in cancer: a potential critical topic for translational proteomic research.A RhoG-mediated signaling pathway that modulates invadopodia dynamics in breast cancer cells.Role of EHD2 in migration and invasion of human breast cancer cells.Podocalyxin-Like Protein 1 Regulates TAZ Signaling and Stemness Properties in Colon Cancer.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Identification of LEA, a podocalyxin-like glycoprotein, as a predictor for the progression of colorectal cancer
P2860
Q21146638-6F481D6D-BF4D-4015-93B2-BF39E5583288Q27303569-AE8E8670-8367-4570-B79F-CB4B32BEEBADQ27338644-BAAEC4FF-2A12-4B44-A72D-8380D90DC91FQ28383915-BF2D1838-409B-4150-AAA2-A11AF2C59705Q30667736-48E533B3-5A16-48C7-A6DD-9EF89F5C91DBQ35615163-0081D8B0-AF5A-4E12-90E5-C458C4C60A06Q36235848-AC20873E-C2BC-4FC6-A37C-AA350FFC2AF6Q36236781-4E51EF47-C778-4D98-A0FA-8A66BE590C47Q36886612-6A477CA9-78FE-4200-98AB-8336DAFFAFCEQ37154185-2BE6326D-F425-4127-84A4-FF9E78F4EAD1Q37580365-E4976B7C-D0E9-4026-80DD-99250143069FQ37735632-090B7FFC-A5EC-4BDF-8CF9-E24009C44054Q38259585-BE85649B-ED5F-4DD8-92C4-0CB02719835EQ38633203-EE53C224-E7DE-4D83-803D-5B0D84D4FD2BQ38716292-5A9EF721-62F2-45C7-84A0-A361DB1591BCQ41626972-D6D322BA-AB37-439D-AAE9-B0DC2125382CQ47159490-D4B79287-89D7-40ED-92A9-644FCC2AB699Q47860795-D42198FD-0AEE-404E-BD4C-2432D4CAACD1Q57112164-B01DE235-D803-4C0B-BC82-68CA10B382D6
P2860
Podocalyxin-like 1 promotes invadopodia formation and metastasis through activation of Rac1/Cdc42/cortactin signaling in breast cancer cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@en
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@nl
type
label
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@en
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@nl
prefLabel
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@en
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@nl
P2093
P2860
P356
P1433
P1476
Podocalyxin-like 1 promotes in ...... naling in breast cancer cells.
@en
P2093
Cheng-Wei Lin
Chu-Hung Chung
Han-Chung Wu
Kuo-Lung Lou
Li-Tin Chiou
Mei-Ying Liao
Min-Siou Sun
Yi-Hsuan Chi
P2860
P304
P356
10.1093/CARCIN/BGU139
P407
P50
P577
2014-06-26T00:00:00Z